-Using a splanchnic nervespinal cord preparation in vitro that could spontaneously generate sympathetic nerve discharge (SND), we investigated the roles of intraspinal GABA B receptors in the regulation of SND. Despite an age-dependent difference in sensitivity, bath applications of baclofen (Bac; GABA B-receptor agonist) consistently reduced SND in a concentration-dependent manner. The drug specificity of Bac in activation of GABA B receptors was verified by application of its antagonist saclofen (Sac) or CGP-46381 (CGP). Sac or CGP alone did not change SND. However, in the presence of Sac or CGP, the effects of Bac on SND inhibition were reversibly attenuated. The splanchnic sympathetic preganglionic neuron (SPN) was recorded by blind whole cell, patch-clamp techniques. We examined Bac effects on electrical membrane properties of SPNs. Applications of Bac reduced excitatory synaptic events, induced membrane hyperpolarizations, and inhibited SPN firing. In the presence of 12 mM Mg 2ϩ or 0.5 M TTX to block Ca 2ϩ -or action potential-dependent synaptic transmissions, applications of Bac induced an outward baseline current that reversed at Ϫ29 Ϯ 6 mV. Because the K ϩ equilibrium potential in our experimental conditions was Ϫ100 mV, the Bac-induced currents could not simply be attributed to an alteration of K ϩ conductance. On the other hand, applications of Bac to Cs ϩ -loaded SPNs reduced Cd 2ϩ -sensitive and high-voltage-activated inward currents, indicating an inhibition of voltage-gated Ca 2ϩ currents. Our results suggest that the activation of intraspinal GABAB receptors suppresses SND via a mixture of ion events that may link to a change in Ca 2ϩ conductance.
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intermediolateral cell column; hypertension; postnatal maturation; autonomic nervous system ADMINISTRATIONS OF BACLOFEN (Bac), a GABA B -receptor agonist, have been suggested as useful treatments for certain neurogenic disorders, such as epilepsy (32, 69) , muscular spasticity (19, 37, 68) , pain (56) , and hypertension (6, 29) . Although the reason why Bac is effective in alleviating these disorders is not clear, it is possible that Bac can correct the anomaly of GABA B -receptor-mediated neurotransmission underlying these disorders. For instance, an overexpression of GABA B receptor in the nucleus tractus solitarius of the spontaneously hypertensive rat is involved in the diminution of baroreflex sensitivity and the development of chronic hypertension (20, 77) . Clinically, intrathecal Bac therapy is a popular and safe treatment for chronic pain and severe spinal spasticity (50, 56) . However, Bac-induced effects on sympathetic regulation at the spinal level seem to receive little attention.
In animal experiments, along the hierarchy of the neural axis, it has been shown that GABA B receptors exert multifarious effects on sympathetic regulation. Administrations of Bac may reduce catecholamine or acetylcholine release by acting on the peripheral GABA B receptors that are located presynaptically on the post-or preganglionic sympathetic nerve terminals (3, 34, 48, 51) . Intrathecal administration of Bac to the thoracic spinal cord decreases blood pressure and heart rate (33). However, intraperitoneal or intracerebroventricular administration of Bac leads to a general excitation of sympathetic activity (49, 53) or elicits biphasic pressor and depressor responses (64) . At the brain level, focal applications of Bac inhibit the presympathetic neurons in the rostral ventrolateral medulla (39) . There, GABA B receptors exert tonic inhibitory effect on sympathoexcitation (4) . Similarly, at the spinal level, GABA B receptors are tonically active to inhibit the cardiovascular sympathetic preganglionic neuron (SPN) (28, 30) . Although these in vivo studies had indicated a general GABA Breceptor-mediated reduction of central sympathetic outflow, the underlying mechanisms were largely unknown.
GABA B receptors are generally considered as one of the presynaptic elements that can reduce synaptic strength (2, 15, 16) . The inhibitory effects of GABA B receptors on neurotransmission could have been coupled with their modulations of voltage-gated channel activities. Activation of GABA B receptors attenuates high-voltage-activated Ca 2ϩ currents in a variety of neurons (8, 13, 21, 27, 70) . Bac also enhances voltagedependent or the inwardly rectifying K ϩ currents (26, 38, 57, 63) . With regard to the sympathetic control at the spinal levels, there is evidence indicating a presynaptic action of GABA B receptors, which may attenuate excitatory synaptic inputs to SPNs (47, 75) . However, there was no evidence indicating that, intrinsic to SPNs, GABA B receptors would regulate their voltage-gated channel activities.
Activities of SPNs are not driven only by the commands from the brain. An isolated spinal cord can generate substantial amounts of sympathetic activities (54, 58, 65, 71) . Using a splanchnic nerve-spinal cord preparation, we have demonstrated that three or less thoracic spinal segments in vitro contain sufficient neural components to generate a sympathetic nerve discharge (SND) (62) . The display of SND patterns in either tonic or bursting form is regulated by a spontaneous GABAergic activity acting on ionotropic GABA A receptors (60, 62) . In the spinal cord of rats, metabotropic GABA B receptors are present (10, 14, 66) . Thus it would be interesting to know whether the intraspinal GABA B receptors, being deprived from extraspinal synaptic inputs, were endogenously active to modulate sympathetic outflow.
In this study using an in vitro experimental model that had a better control of drug working concentrations, we aimed to determine GABA B -receptor-mediated effects on SND and the related ionic mechanisms underlying the regulation of sympathetic outflow from the thoracic spinal cord. We hypothesized that, similar to GABA A receptors, intraspinal GABA B receptors were endogenously active and would exert a tonic suppression of spinal SND. We also hypothesized that Bacinduced suppression of SND could be attributed to an attenuation of excitatory synaptic events to SPNs or a direct inhibition of SPN excitability due to an enhancement of K ϩ or a reduction of Ca 2ϩ currents. Our data not only confirmed the presence of somatodendritic GABA B receptors on SPNs but also indicated complex ion events underlying Bac-induced SND suppression.
MATERIALS AND METHODS
General procedures. Neonatal Sprague-Dawley rats [postnatal (P) days [1] [2] [3] [4] [5] [6] [7] were used in this study, and all of the experimental protocols were approved by the Institutional Animal Care and Utilization Committee (protocol no. RRaIBMSC2003014). Methods in preparing a splanchnic nerve-thoracic spinal cord were modified from the procedures, as previously described (59, 62) . Briefly, the nervecord preparation was fixed onto a recording chamber containing 8 ml 95% O 2-5% CO2 equilibrated artificial cerebrospinal fluid (aCSF; in mM: 128 NaCl, 3 KCl, 1.5 CaCl2, 1.0 MgSO4, 24 NaHCO3, 0.5 NaH2PO4, 30 D-glucose, and 3 ascorbate) and superfused at a rate of ϳ16 ml/min. A suction electrode placed on the proximal end of the splanchnic nerves was used to record compound action potentials, which were then amplified and filtered (WPI, DAM50; band pass: 0.1-1 kHz). All signals were stored on a pulse-code modulation tape recorder (Neuro-Corder, DR-890) for offline analysis. The amount of nerve discharge was measured by a time-based integrator (Gould, 13-4615-70; resetting every 5 s) to obtain total SND (͐ 0-5 SND) or a leaky integrator (discharging time constant: 15 ms) to display the envelope of SND (͐ SND). The background level of neural recording was determined after a blockade of Ca 2ϩ -dependent neural activities by adding 24 mM Mg 2ϩ to the bath solution. During experiments, the bath temperature was maintained at 24.5 Ϯ 1°C.
Whole cell, patch-clamp recording. The Bac-induced changes in electrophysiological properties of splanchnic SPNs were examined by using blind, whole cell, patch-clamp techniques. Patch pipettes were pulled from a borosilicate glass (AM-system, 6170) using a horizontal puller (P-97, Sutter Instrument, Navato, CA). The normal pipette solution contained (in mM) 145 potassium-gluconate, 5 NaCl, 10 EGTA, 1 CaCl 2, 1 MgSO4, 4 ATP, and 10 HEPES (adjusted to pH 7.3 by 1 N KOH). When filled with normal pipette solution, the patch pipette had a resistance of 5-8 M⍀, with a liquid junction potential of ϳ8 mV. To examine Ca 2ϩ currents in some experiments, 145 mM potassium-gluconate in the normal pipette solution was replaced with 135 mM cesium-gluconate and 10 mM TEA acetate to reduce K ϩ currents. Membrane currents or potentials were obtained with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) equipped with CV-203BU headstage, which was mounted on a threedimensional micromanipulator. The patch pipette was advanced by steps (2 m) into the tissue and positioned with a motion controller (PMC100, Newport), which also read the depth of pipette tip from the dorsal surface of the spinal cord. Signals were low-pass filtered at 5 kHz and processed by using a data-acquisition system (pClamp 6.0, Axon Instrument). The whole cell membrane capacitance (C m) or recording access resistance was compensated or determined by the patch-clamp amplifier. In voltage-clamp mode, the waveform of current response to a 5-mV pulse was displayed on an oscilloscope to monitor a possible change in the access resistance. Only the results of experiments without an apparent alteration of access resistance were included in the analysis.
Antidromic stimulation of splanchnic SPN and measurements of electrical membrane properties. To determine whether a spinal neuron was the SPN that had its axonal projection to the splanchnic nerves, the nerves were electrically stimulated by delivering square pulses (Յ100 A, 0.2 ms in duration, 0.5 Hz) to activate antidromic action potentials. A splanchnic SPN was then verified by using the following criteria: 1) the spinal neuron had an evoked spike with a fixed onset latency following the stimulation; and 2) the evoked spike was collided or disappeared when a spontaneous spike appeared within the propagation time of an antidromic action potential (Fig. 1) . In practice, following a spontaneous spike, the antidromic onset latency was taken as a conservative estimate of the critical delay for electrical stimuli to activate antidromic spikes (40) . In voltage-clamp mode with a holding potential of Ϫ60 mV (corrected for junction potential), we measured the electrical membrane properties, including whole cell membrane current (I m) and input resistance (Ri). The total resistance of whole cell, patch-clamp recording was determined by calculating the current responses elicited by a rectangular step pulse (Ϫ10 mV, 70 ms), whereas R i was acquired by subtracting the recording access resistance from the total resistance.
Chemicals. Bac (GABA B receptor agonist), saclofen hydrochloride (Sac; GABAB receptor antagonist), and CGP-46381 (CGP; another GABAB receptor antagonist) were purchased from Tocris, whereas glycine (Gly; glycine receptor agonist) and TTX (fast Na ϩ channel blocker) were from Sigma. Concentrated solutions (in mM: 1 Bac, 10 CGP, 200 Gly, 10 Sac, or 0.25 TTX) were prepared by dissolving drugs in water and stored at Ϫ20°C. The final concentration of drugs in the bath solution was obtained by adding an aliquot of concentrated solutions directly to the bath chamber. A cumulative concentrationresponse test was conducted by sequentially raising drug concentrations in the bath solution to determine drug sensitivity. 
where A1 and A2 are the upper and lower asymptotes, respectively, x0 is the half-maximal response, and dx is the width. In practice, the SND before Bac application (100% activity) was set as a fixed asymptote for A 1. The effectiveness of Sac or CGP to antagonize Bac effects was evaluated first with ANOVA followed by post hoc multiple comparison, using adjusted t-test, with P values corrected by Bonferroni procedure. All values are presented as means Ϯ SE. A statistical probability (P) value Ͻ0.05 was considered significant.
RESULTS

Age-dependent Bac effects on the reduction of spinal SND.
Effects of GABA B -receptor activation on spinal SND were investigated by bath applications of Bac (final concentration: 0.1-9.6 M). The spinal SND was reduced by Bac in a concentration-dependent manner (Fig. 2) . Although SND was always reduced, Bac concentration required to achieve a similar extent of inhibition varied substantially between experiments. Our preliminary observations indicated that Bac sensitivity was higher in younger neonates. In seven of the nine experiments (78%) using neonatal rats of younger ages (1-3 days old), a reduction of SND to Ͻ70% of the control activity only required Bac at a concentration Յ 0.4 M. In all experiments using older neonates (5-7 days old; n ϭ 4), a comparable SND inhibition could only be achieved by 1.6 M Bac. Another series of experiments using neonates of different ages was, therefore, conducted to clarify a change in Bac sensitivity during early postnatal stages. Figure 3 shows an age-dependent shift of the concentration-response curves to the right. In older neonates, both effectiveness and potency of Bac on SND inhibition were attenuated. To minimize variations between . Age-dependent attenuation of the potency and effectiveness of Bac on SND inhibition. Bac was cumulatively applied to the bath solution to achieve final concentrations of 0.1-1.6 M for P1, 0.1-3.2 M for P3, and 0.4 -9.6 M for P5 rats (n ϭ 5 for each age group). In each group, the reduction of SND in response to Bac was well described by a sigmoidal curve (r ϭ 0.9843, 0.9672, and 0.9704 for P1, P3, and P5 group, respectively). The concentrations of Bac required to achieve half-maximal responses of SND inhibition for the age group of P1, P3, and P5 was estimated as 0.16, 0.34, and 2.67 M, respectively. The effectiveness of Bac as revealed by the maximal response of SND inhibition was attenuated in an age-dependent manner. Values are means Ϯ SE.
experiments, the neonatal rats of similar ages were carefully selected for the same tests in the following experiments.
Antagonizing Bac-induced SND suppression by Sac or CGP. To evaluate the specificity of Bac in activating GABA B receptors, Bac effects on SND suppression were challenged by adding Sac or CGP. Due to the age-dependent sensitivity to Bac, nerve cord preparations from neonates of various ages were treated with different Bac concentrations to produce a SND suppression to ϳ50% of the control activity. The selected Bac concentrations would allow a reversible response in repetitive drug applications (Fig. 2) . Applications of 100 M Sac or CGP alone did not change SND (Fig. 4, B and C) . However, in the presence of Sac or CGP, Bac effects on SND suppression were significantly reduced (Fig. 4, A-C) . The specificity of CGP in antagonizing Bac effects was further verified by examining whether CGP could reduce Gly-induced SND suppression. Applications of 6 mM Gly reduced SND to 27 Ϯ 4% of control activity (n ϭ 5). This Gly-induced SND suppression was not affected by the pretreatment of 100 M CGP (Fig. 4D) .
Bac effects on the spontaneous firing and membrane potential of splanchnic SPNs. SPNs were recorded by using blind whole cell, patch-clamp techniques to elucidate the causes of Bac-induced SND suppression. Electrical stimulations of the splanchnic nerves successfully elicited antidromical action potentials with fixed onset latencies of ϳ22-56 ms in 44 spinal neurons (Fig. 1) . Under extracellular recording conditions, most splanchnic SPNs (66%) were spontaneously active, with the average firing rates of ϳ0.1-2 Hz. Under voltage-clamp conditions, we determined passive membrane properties, including C m and R i , which varied substantially in different SPNs (C m : 0.5-4.2 pF; R i : 180 -650 M⍀). Under current-clamp conditions, applications of Bac always reduced SND and SPN firing (n ϭ 5). However, the reduction of SPN firing might not always be accompanied with a membrane hyperpolarization (n ϭ 2). Prominent membrane hyperpolarizations (Ϫ6.5 Ϯ 2.1 mV) were observed in three SPNs, an example shown in Fig.  5 . Figure 5 also shows that application of Bac reduces the occurrence of excitatory postsynaptic potentials.
Bac-induced changes in baseline I m and whole cell R i . Under voltage-clamp conditions, SPNs were held at Ϫ60 mV. A time series plot was constructed by sampling I m and R i with a frequency of every 10 s to examine Bac-induced changes along the time course (Fig. 6) . Bac was applied to the nerve cord preparation when its synaptic transmission was intact or when it was interrupted by adding 12 mM Mg 2ϩ or 0.5 M TTX to aCSF. Figure 7 summarizes the changes of I m and R i elicited by applications of 5 M Bac. Bath applications of Bac to the cord with intact synaptic transmissions elicited small outward baseline I m (7.6 Ϯ 1.7 pA, P Ͻ 0.01 by t-test, n ϭ 5); this effect persisted in the presence of 12 mM Mg 2ϩ (16.0 Ϯ 6.1 pA, P Ͻ 0.05, n ϭ 6) or 0.5 M TTX (15.9 Ϯ 6.2 pA, P Ͻ 0.01, n ϭ 7). In the presence of 0.5 M TTX and 100 M Cd 2ϩ , applications of Bac also elicited outward baseline I m (11.3 Ϯ 3.2 pA, n ϭ 3). Thus applications of 5 M Bac consistently produced hyperpolarizing outward baseline currents in a total of 21 SPNs. The Bac effects on R i , however, varied between SPNs. In all of the trials in which 12 mM Mg 2ϩ were used to reduce synaptic transmission, applications of Bac slightly increased R i . Statistically, the consistent Bac effects led to a small but significant increase of R i ( Fig. 7 ; 18 Ϯ 6%, P Ͻ 0.05 by t-test). In the trials when the synaptic transmission remained intact or was reduced by TTX, applications of Bac did not change R i in a consistent manner. Figure 6 shows that the occurrence of outward baseline I m elicited by Bac is largely not accompanied by a simultaneous alteration of R i , even though Bac may induce a transient inward I m with a concomitant rise of R i .
Bac-induced changes of whole cell, current-voltage relationships. Previous studies have indicated that all of the SPNs innervating the adrenal medulla express a Ba
2ϩ /Cs ϩ -sensitive and hyperpolarization-activated inwardly rectifying conductance (74) . To decipher whether splanchnic SPNs had similar currents that might be enhanced by Bac, the whole cell, current-voltage (I-V) relationship was determined by measuring the current responses elicited by voltage pulses from Ϫ100 to Ϫ40 mV, with a step increment of 10 mV. Experiments were conducted in the presence of 0.5 M TTX, using normal pipette solution, and without the leak subtraction of passive current responses. Figure 8 shows that the whole cell I-V curve is linear, indicating that this SPN does not have inwardly rectifying conductances being activated by hyperpolarization. In this series of experiments (n ϭ 4), an application of 5 M Bac always induced outward baseline I m (26 Ϯ 7 pA), but it might either decrease (Ϫ19 Ϯ 4%, n ϭ 3) or increase (ϩ22%, n ϭ 1) the slope of I-V curves. The I-V curves for control and Bac converged at Ϫ29 Ϯ 6 mV (n ϭ 4), a potential that was very different from K ϩ equilibrium potential (E K ϭ Ϫ99.7 mV). In Cs ϩ -loaded SPNs with external 0.5 M TTX, applications of 5 M Bac still caused an outward baseline I m (19 Ϯ 4 pA, n ϭ 5), which was reversed by application of 100 M CGP.
Bac reversibly reduces Cd 2ϩ -sensitive and high-voltageactivated inward currents in Cs
ϩ -loaded SPNs. Bac effects on high-voltage-activated Ca 2ϩ current were examined in Cs ϩ -loaded SPNs. To acquire high-voltage-activated Ca 2ϩ currents, the passive current responses elicited by the voltage pulses were subtracted by using a P/4 protocol, i.e., 4 prepulses with 1 ⁄4 amplitude and reversed polarity were given before the full-size test pulse. The voltage pulses depolarizing Cs ϩ -loaded SPNs less than or equal to Ϫ20 mV always induced inward currents. Without any treatment, the run-down of highvoltage-activated inward currents was apparent along the time course (decaying rate: Ϫ4.4 Ϯ 1.1 %/min, n ϭ 5). Therefore, we examined the changes induced by drug applications in a time series plot, which was acquired by determining the voltage-gated currents in response to successive rectangular depolarizing voltage pulses (Ϫ10 mV, 76 ms, 0.1 Hz). As shown in Fig. 9 , application of 5 M Bac promptly reduced highvoltage-activated inward currents, which were reversed by adding 100 M CGP. This high-voltage-activated inward cur- rent was abolished by 100 M Cd 2ϩ . Using a trend line to correct the time-dependent, run-down, quantitative analysis revealed that Bac applications significantly reduced the inward currents by Ϫ30 Ϯ 4% (P Ͻ 0.005, n ϭ 5). For comparison, another group of SPNs was recorded by using normal pipette solution, and tests were conducted in the presence of 0.5 M TTX and 100 M Cd 2ϩ (n ϭ 5). Under these conditions, high-voltage pulses elicited outward currents. A time series plot revealed that the outward currents were not affected by applications of Bac or CGP (Fig. 10) .
DISCUSSION
We have demonstrated that Bac activates intraspinal GABA B receptors and inhibits the spinally generated SND. Surprisingly, Bac sensitivity in SND suppression is age dependent, suggesting a functional change of intraspinal GABA B receptors in sympathetic regulation at early postnatal stages. The inhibition of SND could be attributed to both the diminution of excitatory synaptic potentials to SPNs and the elicitation of outward baseline currents that directly hyperpolarized SPNs themselves. The appearance of this hyperpolarizing current in SPNs seems to depend on a mixture of ion events that may not lead to a concomitant change in passive membrane properties. Another new finding is that activation of somatodendritic GABA B receptors on SPNs reduces high-voltageactivated Ca 2ϩ currents. Our findings indicate that intraspinal GABA B -receptor activities suppress central sympathetic outflow through mechanisms both antecedent and intrinsic to SPNs.
Age-dependent sensitivity of Bac: a clinical implication. The age difference of Bac sensitivity in SND inhibition suggests that GABA B receptors undergo postnatal changes. Molecular biological cloning of GABA B receptors has demonstrated the presence of different clones coding for GABA B -receptor subunits, namely, GABA B R1a/b and GABA B R2. The combination of these two clones to form a heterodimer (GABA B R1 ϩ GABA B R2) is required to obtain full biological activity (11, 21, 72, 76) . Developmentally, the expression of GABA B R1a/b splice variants is undergoing a postnatal change, showing a shift from GABA B R1a in neonatal to GABA B R1b in adult stages (22) . The functions of GABA B receptors also undergo postnatal development (7, 22, 41, 43, 67, 78) . Intriguingly, the autonomic nervous system is not mature at birth (5, 25, 31) . Thus, in terms of the sympathetic control at the spinal level, alterations of Bac sensitivity may occur, because the reconstitution of the receptor subunits can, in turn, affect the binding affinity of Bac (43) or even their coupling with G protein (1). Although we have not resolved the exact mechanisms, our results strongly suggest that a prominent change of spinal GABA B receptor plays a role in modulating the sympathetic outflow during postnatal maturation.
Our findings have some clinical implications. In our experiments, bath application of Bac to an in vitro spinal cord preparation simulates the regimen that uses intrathecal Bac to alleviate autonomic dysfunction (6) . We observed that Bac in activating GABA B receptor consistently reduces SND. This observation clearly suggests an overall inhibition of the sympathetic outflow at the spinal level during intrathecal administration of Bac. However, the ability of Bac to inhibit SND largely depends on the age of neonates. The age-dependent Bac sensitivity in SND inhibition could not be due to the thickness of tissue as animals age. In one of our laboratory's previous studies, bath applications of N 6 -cyclopentyladenosine (CPA; adenosine A 1 -receptor agonist) also reduced SND (52). We did not find any age-dependent CPA effect as Bac induced. Besides, compared with CPA, Bac has a lower molecular weight (of Bac and CPA: 213.7 and 335.4, respectively), which presumably makes Bac a better permeate than CPA and allows Bac to sink into the tissue faster than CPA. Moreover, as shown in Fig. 2 , the reduction of SND reached a plateau 3-5 min after Bac applications. Thus, given 15 min for each concentration test here, the age difference in Bac sensitivity is unlikely due to the lack of equilibrated time required for drug diffusion. Similar to our findings in age-dependent sympathetic suppression, Bac as an anticonvulsant has a distinct age-related difference in its effectiveness (69) . The evidence suggests a necessity to carefully assess the dose that is required for a Bac regimen on younger individuals.
Activation of somatodendritic GABA B receptors elicited hyperpolarizing outward baseline currents without consistent changes in R i . There were discrepant observations with regard to a direct postsynaptic GABA B -receptor activity in SPNs. In CA3 hippocampal regions, it seems that only the presynaptic GABA B receptors function in early postnatal stages (24) . Similar findings in the SPNs of immature rats (12-20 days old) also have reported that Bac only attenuates excitatory synaptic transmission to SPNs without affecting R i , suggesting a lack of somatodendritic GABA B -receptor-mediated effects on SPNs (75) . However, a recent study by Whyment et al. (73) indicates that applications of 50 M Bac induce a dramatic decrease of R i (ϳ34%), which persists in the presence of TTX and is . Data were collected 5 min after achieving whole cell, patch-clamp configurations to allow diffusion of pipette Cs ϩ into the neuron. Holding potential was Ϫ60 mV. Consecutive rectangular test pulses (76 ms) were given every 10 s to depolarize membrane from holding potential to Ϫ10 mV. Along the time course of tests, each circle represents the peak ICa elicited by the test pulse with leak current subtraction by a P/4 protocol. Raw ICa traces labeled by 1-7 in middle insets are the average responses of 6 consecutive test pulses and correspond to the numbered data points in the time series plot. The plot and raw ICa traces indicate that the high-voltage-activated ICa gradually run down along the time course (1-2), drop abruptly after Bac application (2-3), recover substantially after addition of CGP (4 -5) , and are virtually abolished by Cd 2ϩ (6 -7) . The I-V curves in the bottom right inset were obtained by applying test pulses to depolarize membrane to potentials between Ϫ35 and 25 mV (400 ms, 15-mV increments) at the timing, as solid symbols and arrows indicated in the time series plot. caused by an increase of K ϩ conductance (73) . Under conditions with intact or interrupted synaptic transmissions, given a holding potential at Ϫ60 mV, we found that Bac consistently elicited hyperpolarizing outward baseline currents with inconsistent changes in R i among SPNs. This inconsistency in Bac-induced changes of R i has also been observed in the neurons located in the rostral ventrolateral medulla (39) or some of the SPNs in the thoracic spinal cord (See Fig. 5 in Ref. 73) . Compared with observations from other studies, our results clearly indicate a heterogeneous response in different SPNs that may or may not reveal a discernible postsynaptic GABA B -receptor-mediated effect on R i . We believe that the discrepancy of observations may be due to a complex ion mechanism underlying the hyperpolarizing outward baseline current. This might explain why activation of the somatodendritic GABA B receptors on SPNs did not elicit a concurrent change in R i .
Compared with the inconsistent effects of Bac on R i when the tests were conducted in the presence of 0. (12, 46) . All of these ion events may occur at either presynaptic nerve terminals or postsynaptic somatodendritic area to alter the neuronal excitability. In our studies, we did not find a discernible inwardly rectifying conductance when splanchnic SPNs were hyperpolarized between Ϫ80 and Ϫ100 mV (Fig. 8) . In the SPNs that innervate the adrenal medulla, there is a hyperpolarization-activated inwardly rectifying current, which is sensitive to external Ba 2ϩ or intracellular Cs ϩ and is reduced in K ϩ -free aCSF (74). It was not clear, in our experimental conditions, why we did not find a likely current in splanchnic SPNs. Under physiological conditions, the functional operation of inwardly rectifying K ϩ conductances falls in a potential range between resting level and E K , lending a more hyperpolarized resting level than those neurons without such conductances (44) . Compared with the resting potential of phrenic motoneurons at approximately Ϫ65 mV (61), the SPNs in our studies here, which were examined under the same experimental conditions as for phrenic motoneurons, had a fairly depolarized resting potential at approximately Ϫ50 mV. The resting potentials of those SPNs examined in thin slice preparations are Ϫ48.2 Ϯ 1 mV (17) . Thus the lack of hyperpolarization-activated inward rectification and the fairly depolarized resting potential did not indicate an existence of inwardly rectifying K ϩ conductance in splanchnic SPNs. In our studies, application of Bac still induced hyperpolarizing outward baseline current in Cs ϩ -loaded splanchnic SPNs. Moreover, the I-V curves of control and after Bac were linear and did not converge toward E K . Taken together, our results did not support the notion that Bac reduced SND through an intrinsic mechanism of SPNs attributing to the inwardly rectifying K ϩ conductance. The possibility that Bac reduces SND by an enhancement of inwardly rectifying K ϩ conductances on the pre-SPN spinal neurons, however, cannot be excluded.
Applications of Bac to Cs ϩ -loaded SPNs reduced the Cd 2ϩ -sensitive and high-voltage-activated inward currents. This result indicates a downregulation of high-voltage-activated Ca 2ϩ channel activities by GABA B receptors. In contrast, with TTX and Cd 2ϩ to reduce voltage-gated Na ϩ and Ca 2ϩ currents, activation of GABA B receptors did not affect the high-voltageactivated outward current, thus excluding the involvement of delayed-rectified K ϩ current (Fig. 10) . Bac effects on highvoltage-activated Ca 2ϩ current may not be unique to SPNs. In three of three Cs ϩ -loaded spinal neurons that did not respond to antidromic stimulation of splanchnic nerves, applications of 5 M Bac reduced high-voltage-activated Ca 2ϩ currents (data not shown). Thus it is likely that Bac exerts its effect on SND inhibition via a universal reduction of Ca 2ϩ influx at multiple levels, including SPN, non-SPN, and even pre-SPN spinal neurons. Although how the diminution of high-voltage-activated Ca 2ϩ influx into somatodendritic area of some spinal neurons could reduce SND was unknown, an attenuation of Ca 2ϩ influx into the presynaptic nerve terminals apposing SPNs would decrease excitatory postsynaptic potentials, as we observed in Fig. 5 . Previous studies have shown that SPNs receive prominent intraspinal GABAergic, glycinergic, and glutamatergic inputs (9, 18, 35, 42, 60) . The release of these amino acid neurotransmitters might, therefore, be regulated by presynaptic GABA B receptors.
The source of tonic GABA B -receptor-mediated activity under in vivo conditions is extrinsic to the spinal cord. Under the present in vitro conditions, we did not find significant effects of Sac or CGP. The lack of antagonistic effect suggests an absence of endogenous GABA B -receptor-mediated activity within the spinal cord. This observation is not consistent with those obtained from other in vivo studies that support the notion of a tonic GABA B -receptor-mediated activity at the spinal level (28, 30) . The existence of spinal GABAergic activity is evident, because our laboratory has previously demonstrated that bicuculline or picrotoxin, by eliminating endogenous GABA A -receptor-mediated activities, induces a sympathetic output in bursting forms (60, 62) . Thus the discrepancy of observations between our in vitro and other's in vivo studies cannot be attributed to the lack of endogenous GABAergic activity under the present in vitro conditions. It has been reported that the excitation of SPNs elicited from the dorsal root stimulation is suppressed by Bac (47) . Therefore, the spontaneous GABA B -receptor activity may arise from the local spinal reflex under in vivo conditions. In contrast to the actions of intraspinal GABA A receptors that mainly affect the patterns, rather than the amounts of SND (60) , activation of intraspinal GABA B receptors causes a general reduction of sympathetic outflow. Thus intraspinal GABA B receptors act as a simple target subserving the commands from the extraspinal GABAergic sources for sympathetic regulation.
